NCT05372705 is a NA clinical trial of Short videos in Ecology, sponsored by Yale University.

Who is sponsoring NCT05372705?

NCT05372705 is sponsored by Yale University.

What drugs are being tested in NCT05372705?

Interventions in NCT05372705: Short videos.

What condition does NCT05372705 study?

NCT05372705 studies Ecology, Anxiety.

Is NCT05372705 still recruiting?

NCT05372705 is currently completed. Last updated 12 August 2022.

Last reviewed 2022-08-12 · How we verify

NCT05372705

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reducing Eco-anxiety Using Selfies

Completed NA Last updated 12 August 2022

What this trial tests

NA trial testing Short videos in Ecology in 1,200 participants. Completed in 30 July 2022.

Timeline

15 June 2022

Primary endpoint
20 July 2022

30 July 2022

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	1,200
Start date	15 June 2022
Primary completion	20 July 2022
Estimated completion	30 July 2022
Sites	2 locations across United States

Drugs / interventions tested

Short videos

Conditions studied

Ecology — all drugs for Ecology →
Anxiety — all drugs for Anxiety →

Sponsor

Yale University

Who can join

Adults 14 to 18, any sex, with Ecology or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purposes of this study are to test among adolescent viewers the utility of selfie (TikTok) short video-based interventions to: 1. Reduce ecological anxiety, 2. Increase ecological agency, 3. Compare two different types of messaging, and 4. Examine the role of viewer's gender and race as independent factors on the outcomes of interest.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Climate change hopefulness, anxiety, and behavioral intentions among adolescents: randomized controlled trial of a brief "selfie" video intervention.
Benoit L, R Lowe S, Thomas I, Amsalem D, et al · · 2025 · cited 3× · PMID 39987228 · DOI 10.1186/s13034-025-00872-x

Verify or expand the search:

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05372705 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 12 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05372705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing